These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35073730)

  • 1. Liquid biopsy: the value of different bodily fluids.
    Santos V; Freitas C; Fernandes MG; Sousa C; Reboredo C; Cruz-Martins N; Mosquera J; Hespanhol V; Campelo R
    Biomark Med; 2022 Feb; 16(2):127-145. PubMed ID: 35073730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
    Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
    Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions.
    Luo F; Wang X; Ye C; Sun H
    Cancer Control; 2024; 31():10732748241292019. PubMed ID: 39431347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine-Based Liquid Biopsy for Nonurological Cancers.
    Jain S; Lin SY; Song W; Su YH
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.
    Wu S; Li R; Jiang Y; Yu J; Zheng J; Li Z; Li M; Xin K; Wang Y; Xu Z; Li S; Chen X
    Biomed Pharmacother; 2023 Sep; 165():115027. PubMed ID: 37354812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Derived Biomarkers in Liquid Biopsy of Glioblastoma.
    Khristov V; Lin A; Freedman Z; Staub J; Shenoy G; Mrowczynski O; Rizk E; Zacharia B; Connor J
    World Neurosurg; 2023 Feb; 170():182-194. PubMed ID: 36347463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature.
    Shoda K; Saito R; Maruyama S; Furuya S; Akaike H; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
    Surg Today; 2021 Jun; 51(6):849-861. PubMed ID: 32979121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.
    Quirico L; Orso F
    Cancer Drug Resist; 2020; 3(2):117-139. PubMed ID: 35582611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates of liquid biopsy in oral cancer and multiomics analysis.
    Zhang X; Li B
    Oral Dis; 2023 Jan; 29(1):51-61. PubMed ID: 34716963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
    Yang SR; Mooney KL; Libiran P; Jones CD; Joshi R; Lau HD; Stehr H; Berry GJ; Zehnder JL; Long SR; Kong CS; Kunder CA
    Cancer Cytopathol; 2020 Jan; 128(1):43-56. PubMed ID: 31751001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives.
    Ibrahim J; Peeters M; Van Camp G; Op de Beeck K
    Eur J Cancer; 2023 Jan; 178():91-113. PubMed ID: 36427394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids.
    Neoh KH; Hassan AA; Chen A; Sun Y; Liu P; Xu KF; Wong AST; Han RPS
    Biomaterials; 2018 Jan; 150():112-124. PubMed ID: 29035737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
    Yoshioka Y; Katsuda T; Ochiya T
    Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies.
    Wang S; Zhang K; Tan S; Xin J; Yuan Q; Xu H; Xu X; Liang Q; Christiani DC; Wang M; Liu L; Du M
    Mol Cancer; 2021 Jan; 20(1):13. PubMed ID: 33430880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy.
    Clack K; Soda N; Kasetsirikul S; Mahmudunnabi RG; Nguyen NT; Shiddiky MJA
    Small; 2023 Apr; 19(15):e2205856. PubMed ID: 36631277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
    Yokoi K; Yamashita K; Watanabe M
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.